Oseltamivir GH Oseltamivir (as phosphate) 45 mg capsule blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

oseltamivir phosphate, Quantity: 59.114 mg

Disponibbli minn:

Lupin Australia Pty Limited

Għamla farmaċewtika:

Capsule, hard

Kompożizzjoni:

Excipient Ingredients: ethanol absolute; croscarmellose sodium; pregelatinised maize starch; purified talc; povidone; sodium stearylfumarate; titanium dioxide; purified water; Gelatin; iron oxide black

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

10's

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Oseltamivir is indicated for the treatment of infections due to influenza A and B viruses in adults and children including full-term neonates. Treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,Oseltamivir is indicated for the prevention of influenza in adults and children aged 1 year and older. Vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Sommarju tal-prodott:

Visual Identification: Size 4 capsule with grey opaque cap and body imprinted with 45 mg on cap and LU on body in blue ink containing white to off-white granular powder.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2020-12-03